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ABSTRACT
The feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) may cause persistent, lifelong and 
lethal infections in domestic and wild felids worldwide. FIV has been confirmed in most Felidae species, while 
FeLV infection is rare among non-domestic cats. The view that retroviruses are pathogenic in domestic cats but not 
in other free-ranging felid species was disproved by recent findings of retroviral pathology in several wild felids. The 
epidemiology of retroviral infections in felids in Croatia was only investigated in urban domestic cats, while there 
are no data for wild cat species. As the reintroduced Dinaric lynx (Lynx lynx) population suffers from low genetic 
diversity, which reduces their ability to adapt to new viral outbreaks, the health status of this lynx population is of 
particular concern. Two different commercial immunochromatographic assays were used for qualitative detection of 
FIV antibodies and FeLV antigens, while PCR was used for amplification of proviral gag and env genes in Eurasian 
lynx blood samples. All the 17 Eurasian lynx samples collected between 2001 and 2019 tested negative in both 
immunochromatographic and molecular tests. Even though our sample size was rather small, considering the fact that 
the population size of lynx in Croatia is estimated at 40 - 60 animals, our results can be considered representative for 
the population’s health status. Also, data about retroviral prevalence in Eurasian lynxes are scarce, so any new findings 
are very valuable.
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Introduction
Feline immunodeficiency virus (FIV) and 
feline leukemia virus (FeLV) are significant 
pathogens of domestic and wild felids worldwide. 
Both are enveloped RNA viruses, members of 
the Retroviridae family, where FIV is classified 
to the Lentivirus genus, while FeLV belongs to 
the Gamaretroviridae. Due to the enzyme reverse 
transcriptase and integration of the provirus into 
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Three felid species are present in Croatia - the 
domestic cat (Felis catus), the European wild cat 
(Felis silvestris silvestris) and the Eurasian lynx 
(Lynx lynx), but the epidemiological features of 
retroviral infections have only been investigated 
in domestic cats from the Zagreb urban area, 
confirming a high rate of FIV (18.51%) and FeLV 
(14.5%) seropositive cats (PERHARIĆ et al., 
2018). So, the goal of our study was to determine 
the prevalence of retroviruses in the Eurasian lynx 
population in Croatia. 
The size of the lynx population in Croatia today 
is estimated at 40 - 60 individuals, all of them 
being offspring of six individuals reintroduced 
from Slovakia to the Dinaric Mountains in 
1973 (SINDIČIĆ et al. 2016). The health status 
of the reintroduced Dinaric lynx population is 
of particular concern, because the population 
suffers from low genetic diversity and inbreeding 
depression (SINDIČIĆ et al., 2013). Decreased 
genetic diversity in wild populations reduces the 
ability to adapt to new viral outbreaks, such as well-
known cases of coronavirus in cheetahs (PEARKS 
WILKERSON et al., 2004) or different infectious 
diseses in Iberian lynxes (LÓPEZ et al., 2014).
Materials and methods
The research was performed on 17 wild and 
captured Eurasian lynx (Lynx lynx) blood samples. 
The animals were sampled in Croatia, in the areas 
of Gorski kotar and Lika (Fig. 1), in the period 
from 2001 to 2019. The animals were captured 
and equipped with radio collars for activity and 
movement research, except one animal that was 
found in the vicinity of an urban area, with an injured 
leg and malnourished. This subadult male lynx died 
the day after it was captured, with purulent necrotic 
hepatitis and septicaemia found at necropsy. Apart 
from this subadult, all the animals were adults, 6 
were females and 11 males.
Blood samples were collected from the vena 
cephalica antebrachi or v. saphena into EDTA-
coated tubes by an aseptic method. Retroviral status 
was initially analyzed by two different commercial 
immunochromatographic assays - FASTest® FeLV-
FIV, MEGACOR Diagnostik GmbH and IDEXX 
SNAP Combo Plus, IDEXX Laboratories. Both 
the host cell genome, both viruses cause persistent, 
lifelong and potentially lethal infections. FIV causes 
progressive immune dysfunction due to a decrease 
in CD4+ T-lymphocytes, leading to acquired 
immunodeficiency syndrome (AIDS). FeLV 
infection usually causes bone marrow suppression, 
lymphoma or viral immunosuppression. Retroviral 
infected domestic cats may have a prolonged period 
with no clinical signs of the disease, but finally 
acquire life threatening secondary and opportunistic 
infections (BULL et al., 2003; HARTMANN, 2011; 
SELLON and HARTMANN, 2012). 
FIV is mainly shed naturally in saliva and is 
transmitted through bite wounds. Beside bites, 
transplacental and veneral routes, colostrum and 
milk are also confirmed modes of FIV transmission 
(ROGERS and HOOVER, 2002; COATS, 2005; 
LEVY et al., 2006). FeLV transmission usually 
occurs through the oronasal route after close contact 
with salivary secretions, but viremic felids may also 
shed the virus in nasal secretions, faeces, urine and 
milk. Vertical transmission of FeLV has also been 
documented, as well as through cat fleas (PACITTI 
et al., 1986; VOBIS et al., 2003; GOMES-KELLER 
et al., 2009). 
Both retroviral infections are endemic in 
domestic cat populations worldwide, with estimated 
FIV prevalence from 1 to 14% in cats without 
clinical signs, and up to 44% in cats expressing 
clinical symptoms (HARTMANN, 1998). The 
overall prevalence of FeLV in the mixed domestic 
cat population ranges from 1 to 6% (LEVY et al., 
2006; GLEICH et al., 2009; HELLARD et al., 
2011). FIV has been confirmed in most of the 37 
Felidae species (review in O’BRIEN et al., 2012), 
while FeLV infection is rare among non-domestic 
cats. Phylogenetic results confirm that although 
FIV can occasionally move from species to species 
(TROYER et al., 2008), these events are rare, and 
most felids carry their own distinct version of the 
virus (LANGLEY et al., 1994; BARR et al., 1997; 
PECON-SLATTERY et al., 2008). In contrast, 
FeLV infections are mostly reported in captive 
animals that acquired the virus by physical contact 
with FeLV-infected domestic cats (KENNEDY-
STOSKOPF, 1999; CUNNINGHAM et al., 2008). 
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tests are used for qualitative detection of FIV 
antibodies for FIV gp40 trans-membrane protein, 
and qualitative detection of FeLV p27 specific 
antigens in the whole blood, plasma or serum. The 
reported sensitivity and specificity for domestic cats 
for FASTest® FIV were 96.4% and 99.2%, and for 
FASTest® FeLV 94.7% and 98.8% (HARTMANN 
et al., 2007). Similar results were published for 
IDEXX SNAP Combo, sensitivity and specificity 
for FIV infection were 100% and 99.6%, and for 
FeLV 92.3% and 97.3% (HARTMANN et al., 
2007). Both diagnostic assays were performed 
according to the manufacturer’s instructions.
Prior to molecular diagnostic for FIV and FeLV, 
DNA was extracted from EDTA-treated lynx whole 
blood. A commercially available QIAamp DNA 
Mini Kit (Qiagen, Hilden, Germany) was used 
for DNA extraction. Molecular diagnostics for 
FIV infection were performed with two different 
PCR protocols. For detection of proviral gag gene 
primers FIV-1026F (5ʹ - GGC ATA TCC TAT TCA 
ACC AG - 3ʹ) and FIV 1700R (5ʹ - AAG AGT TGC 
ATT TTA TAT CC - 3ʹ) were used for amplification 
(CAMMAROTA et al., 1996; STEINRIGL and 
KLEIN, 2003). The second PCR protocol was used 
for proviral env gene detection with primers FIV-
7316F (5ʹ - ATA CCA AAA TGT GGA TGG TG - 
3ʹ) and FIV-7868R (5ʹ - TGC AAG ACC AAT TTC 
CAG CA - 3ʹ) (STEINRIGL and KLEIN, 2003). 
For FeLV infection nested PCR was performed 
for gag gene amplification. The first set of primers 
(outer primers) was U3-F1 (5ʹ - ACA GCA GAA 
GTT TCA ACG CC - 3ʹ) and G-R1 (5ʹ - GAC CAG 
TGA TCA AGG GTG AG - 3ʹ). The PCR product of 
this first round served as a template for the second 
round of PCR with nested primers U3-F2 (5ʹ - GCT 
CCC CAG TTG ACC AGA GT - 3ʹ) and G-R2 
(5ʹ - GCT TCG GTA CCA AAC CGA AA - 3ʹ) 
(KAEWMONGKOL et al., 2007). For both FIV and 
FeLV, agarose gel electrophoresis was performed to 
visualize the PCR product. 
results and discussion
All 17 Eurasian lynx tested negative for FIV and 
FeLV using two different immunochromatographic 
assays. The FIV proviral gag and env genes, and 
the FeLV proviral gag gene were not amplified in 
any of the 17 samples. Even though our sample 
Fig. 1. Map of Croatia, with the brown area indicating Eurasian lynx distribution, and blue dots indicating  
sampling locations
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size was rather small, considering the fact that 
the population size of lynx in Croatia is estimated 
at 40 - 60 animals, our results can be considered 
representative for the population health status. 
Also, data about retroviral prevalence in Eurasian 
lynx are scarce so any new finding is very valuable. 
The only available data are serological tests for 
FeLV in free ranging and captive animals from 
Sweden, and FeLV and FIV in free ranging lynxes 
from Switzerland, which were all negative (LUTZ 
et al., 1992; RYSER-DEGIORGIS et al., 2005). 
Most data about the retroviral status of lynx 
in Europe come from Spain, where there is an 
endangered Iberian lynx (Lynx pardinus) population. 
The absence of FIV antibodies was reported in Iberian 
lynxes sampled between 1989 and 2007 (ROELKE 
et al., 2008; LUACES et al., 2008; MILLÁN et al., 
2009, MELI et al., 2009), and confirmed by qPCR 
on 311 individuals sampled between 2004 and 2017 
(LOPEZ et al., 2019). Beside negative molecular 
tests, one animal tested positive for FIV antibodies 
by ELISA and immunoblot assay, but showed 
no signs of the disease (LOPEZ et al., 2019). In 
contrast, an FeLV epidemic caused the death of six 
Iberian lynxes in 2007, while in the same period 
an additional seven lynxes were found to be FeLV-
positive and survived. Several of the FeLV-infected 
lynxes showed clinical signs and/or hematological 
abnormalities, such as anemia, lymphopenia or 
neutropenia, compatible with the FeLV infection 
also observed in domestic cats (MELI et al., 
2009). As only a few cases of FeLV infection were 
observed prior to 2007 (LUACES et al., 2008), it is 
likely that FeLV infection is rare in lynxes, is not 
readily carried within the lynx population, and most 
likely originates from domestic cats (MELI et al., 
2009). GERET et al. (2011) suggest that the severe 
outcome of the FeLV outbreak in 2007 was due 
to the particular susceptibility of the Iberian lynx 
to pathogens. The Iberain lynx population suffers 
from reduced genetic variability (JOHNSON et al., 
2004), as does our Dinaric lynx population, which 
underlines the need for regular monitoring of the 
retroviral status of the population. 
The importance of regular monitoring of 
retroviruses in felids has also been underlined in 
recent publications. Originally, the absence of 
clear clinical pathology among infected felids 
fostered the view that retroviruses are pathogenic 
in domestic cats but not in other free ranging felid 
species (CARPENTER and O’BRIEN, 1995; 
PACKER et. al., 1999; O’BRIEN et al., 2012). 
However, new findings strongly suggest that FIV is 
contributing to the loss of immune competence in 
infected lions (ROELKE et al., 2009), while FeLV 
was proved as a cause of death in Iberain lynxes in 
2007 (MELI et al., 2009), and Florida panthers in 
2001-2006 (CUNNINGHAM et al., 2008). 
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SaŽeTaK
Virus mačje imunodeficijencije (FIV) i virus mačje leukemije (FeLV) mogu uzrokovati trajne, cjeloživotne i 
smrtne infekcije u domaćih i divljih felida širom svijeta. FIV je potvrđen u većine felida, dok je infekcija FeLV-om 
u domaćih mačaka rijetka. Mišljenje da su retrovirusi patogeni u domaćih mačaka, ali ne i u slobodnoživućih felida, 
opovrgnuto je najnovijim istraživanjima retrovirusne patologije u nekoliko divljih felida. Epidemiologija retrovirusnih 
infekcija u felida u Hrvatskoj istraživana je u gradskih domaćih mačaka, dok podaci za divlje mačke ne postoje. Kako 
populaciju reintroduciranog dinarskog risa (Lynx lynx) obilježava niska genetska raznolikost, što smanjuje mogućnost 
prilagodbe na nove virusne zaraze, postoji osobita zabrinutost za zdravstveno stanje ove populacije risa. U radu su 
upotrijebljene dvije različite komercijalne imunokromatografske pretrage za kvalitativnu detekciju protutijela na FIV 
i FeLV antigene, dok je PCR upotrijebljen za umnažanje provirusnih gena gag i env u uzorcima krvi euroazijskog 
risa. Svih 17 uzoraka euroazijskog risa, prikupljenih od 2001. do 2019., bilo je negativno i u imunokromatografskom 
i molekularnom testu. Iako se radi o maloj veličini uzorka, s obzirom na to da je veličina populacije risa u Hrvatskoj 
procijenjena na 40 – 60 jedinki, naši se uzorci mogu smatrati reprezentativnima za zdravstveni status navedene 
populacije. Također, malo je podataka o retrovirusnoj prevalenciji u euroazijskog risa, što novim podacima dobivenim 
ovim istraživanjem daje dodatnu vrijednost.
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